Nova Biomedical News Today

Based on alarming statistics, we need to rethink our approach to identifying and managing CKD.

This product profile highlights the ULTIMA Automated Cell Density/Viability Analyzer, engineered for cell culture scientists who demand high throughput and precision.

The global blood gas and electrolyte analyzer market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Volunteers help identify the next class while illuminating what makes Roanoke a special place. When prospective students apply to medical schools…

Read independent reviews on StatStrip® Glucose from Nova Biomedical on SelectScience

Continuous Ketone Monitoring MarketIn 2023, the Continuous Ketone Monitoring Market is expected to be worth US$ 128.7 million. The market is expected to reach US$ 305.3 million by 2033, expanding at a 9.0% CAGR throughout the forecast period. The continuous ketone monitoring market refers to the market for devices a...

The global point of care diagnostics market revenue to reach USD 82.95 Billion by 2028....

In line with Future Market Insights (FMI) research, the global Network Point Of Care Glucose Testing Industry is set to achieve a significant value, reaching US$ 1.6 billion in 2021 and is projected to soar to US$ 2.5 billion by 2032. This robust growth is substantiated by the data showing that revenue from Accu-Che...

The global point-of-care market is expected to reach $75.5 billion by 2027 from an estimated $45.4 billion in 2022, at a CAGR of 10.7% from 2022 to 2027.

Ketoacidosis is a condition in which the blood turns acidic due to the overproduction of ketones. The life-threatening condition known as diabetic